Principal Financial Group Inc Tg Therapeutics, Inc. Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q3 2024

A detailed history of Principal Financial Group Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 772,188 shares of TGTX stock, worth $27.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
772,188
Previous 46,817 1549.38%
Holding current value
$27.1 Million
Previous $832,000 2070.79%
% of portfolio
0.01%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
BUY
$17.21 - $25.28 $12.5 Million - $18.3 Million
725,371 Added 1549.38%
772,188 $18.1 Million
Q2 2024

Jul 29, 2024
BUY
$13.32 - $19.19 $152,420 - $219,591
11,443 Added 32.35%
46,817 $832,000
Q1 2024

Apr 29, 2024
BUY
$13.02 - $21.3 $17,212 - $28,158
1,322 Added 3.88%
35,374 $538,000
Q4 2023

Feb 07, 2024
BUY
$6.68 - $18.81 $2,752 - $7,749
412 Added 1.22%
34,052 $581,000
Q3 2023

Nov 02, 2023
SELL
$8.36 - $26.5 $154,150 - $488,633
-18,439 Reduced 35.41%
33,640 $281,000
Q2 2023

Aug 07, 2023
SELL
$15.48 - $35.0 $184,165 - $416,395
-11,897 Reduced 18.6%
52,079 $1.29 Million
Q1 2023

May 09, 2023
BUY
$10.23 - $19.34 $249,059 - $470,851
24,346 Added 61.43%
63,976 $962,000
Q4 2022

Feb 09, 2023
BUY
$5.01 - $11.83 $18,647 - $44,031
3,722 Added 10.37%
39,630 $468,000
Q3 2022

Nov 09, 2022
SELL
$4.57 - $8.4 $3,587 - $6,594
-785 Reduced 2.14%
35,908 $213,000
Q2 2022

Aug 10, 2022
SELL
$3.74 - $10.66 $11,982 - $34,154
-3,204 Reduced 8.03%
36,693 $156,000
Q1 2022

May 09, 2022
BUY
$7.81 - $20.45 $6,060 - $15,869
776 Added 1.98%
39,897 $380,000
Q4 2021

Feb 09, 2022
SELL
$15.2 - $35.51 $245,677 - $573,948
-16,163 Reduced 29.24%
39,121 $743,000
Q3 2021

Nov 09, 2021
BUY
$21.78 - $40.45 $40,510 - $75,237
1,860 Added 3.48%
55,284 $1.84 Million
Q2 2021

Aug 10, 2021
BUY
$32.5 - $48.96 $28,502 - $42,937
877 Added 1.67%
53,424 $2.07 Million
Q1 2021

May 10, 2021
BUY
$41.61 - $54.3 $16,435 - $21,448
395 Added 0.76%
52,547 $2.53 Million
Q4 2020

Feb 08, 2021
BUY
$25.27 - $54.9 $400,024 - $869,067
15,830 Added 43.58%
52,152 $2.71 Million
Q3 2020

Nov 06, 2020
SELL
$18.49 - $27.24 $13,109 - $19,313
-709 Reduced 1.91%
36,322 $971,000
Q2 2020

Aug 05, 2020
BUY
$8.9 - $21.84 $105,376 - $258,585
11,840 Added 47.0%
37,031 $722,000
Q1 2020

May 12, 2020
BUY
$7.14 - $15.99 $5,640 - $12,632
790 Added 3.24%
25,191 $247,000
Q4 2019

Feb 05, 2020
BUY
$5.1 - $11.2 $65,075 - $142,912
12,760 Added 109.61%
24,401 $271,000
Q3 2019

Nov 13, 2019
BUY
$5.38 - $8.99 $62,628 - $104,652
11,641 New
11,641 $65,000
Q4 2018

Feb 14, 2019
SELL
$3.44 - $5.76 $38,056 - $63,722
-11,063 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$5.15 - $14.0 $56,974 - $154,882
11,063 New
11,063 $62,000

Others Institutions Holding TGTX

# of Institutions
340
Shares Held
88.5M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.09B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email